GRI GRI Bio, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$1.70
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026

GRI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.70
Market Cap
$3M
P/E (TTM)
-0.0
EPS (TTM)
$-121.80
Revenue (TTM)
Div Yield
ROE
-256.3%
Debt/Equity
52W Range
$0 – $7

GRI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
2-point trend, -100.0%
2020-12-31 2021-12-31
EPS $-121.80
6-point trend, -11283.2%
2020-12-31 2025-12-31
Free Cash Flow $-10M
4-point trend, -22.6%
2021-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
GRI
Peer Median
P/E (TTM)
5-point trend, +100.0%
-0.0
P/B
5-point trend, -100.0%
0.4
0.8
Price / FCF
4-point trend, +100.0%
-0.3

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
GRI
Peer Median
ROA
5-point trend, +17.1%
-166.0%
-62.7%
ROE
5-point trend, -100.4%
-256.3%
-70.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
GRI
Peer Median
Current Ratio
5-point trend, -2.2%
3.3
3.2
Quick Ratio
5-point trend, +105.6%
3.1

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
GRI
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
GRI
Peer Median
EPS (Diluted)
5-point trend, -8477.5%
$-121.80

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
GRI
Peer Median

GRI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 6 analysts
  • Strong Buy 1 16.7%
  • Buy 4 66.7%
  • Hold 1 16.7%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

2 analysts · 2026-08-19
Median target $21.00 +1135.3%
Mean target $21.00 +1135.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-28.6%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-1.61 $-0.91 -0.70%
Dec. 31, 2025 $-116.61 $-29.55 -87.1%
Sept. 30, 2025 $-35.84 $-26.30 -9.5%
June 30, 2025 $-36.68 $-37.05 0.37%
March 31, 2025 $-162.40 $-116.23 -46.2%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
GRI $122.9K -0.0 -256.3%
MBIO -2.5 -30.9%
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
VIVS $4M -0.3 -9.0% -10567.2% -294.8%
CRIS $13M -1.7 -13.4% -80.3% 177.9%
BIAF

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 13
Annual Income Statement data for GRI
Metric Trend 202520242023202220212020
Revenue 2-point trend, -100.0% · · · · $0 $100.0K
R&D Expense 6-point trend, +83.9% $7M $4M $3M $242.0K $5M $4M
SG&A Expense 6-point trend, +336.7% $5M $4M $8M $2M $4M $1M
Operating Expenses 6-point trend, +145.0% $12M $8M $11M $2M $9M $5M
Operating Income 6-point trend, -150.1% $-12M $-8M $-11M $-2M $-9M $-5M
Other Non-op 5-point trend, +0.00 · $0 $250.0K $0 $61.0K $0
Income Tax 2-point trend, +50.0% $3.0K $2.0K · · · ·
Net Income 6-point trend, -147.9% $-12M $-8M $-13M $-3M $-9M $-5M
EPS (Basic) 6-point trend, -11283.2% $-121.80 $-1545.55 $-5018.09 $-24.95 $-1.42 $-1.07
EPS (Diluted) 6-point trend, -11283.2% $-121.80 $-1545.55 $-5018.09 $-24.95 $-1.42 $-1.07
Shares (Basic) 6-point trend, -97.8% 98,162 6,547 2,598 128,994 6,541,097 4,506,216
Shares (Diluted) 6-point trend, -97.8% 98,162 6,547 2,598 128,994 6,541,097 4,506,216
EBITDA 5-point trend, -29.4% $-12M $-8M $-11M $-7M $-9M ·
Balance Sheet 22
Annual Balance Sheet data for GRI
Metric Trend 202520242023202220212020
Cash & Equivalents 6-point trend, +7449.5% $8M $5M $2M $9.0K $4M $109.0K
Prepaid Expense 6-point trend, -35.8% $363.0K $587.0K $1M $303.0K $619.0K $565.0K
Current Assets 6-point trend, +1174.8% $9M $6M $3M $312.0K $8M $674.0K
PP&E (Net) 6-point trend, +50.0% $3.0K $4.0K $8.0K $4.0K $0 $2.0K
PP&E (Gross) 4-point trend, +42.3% $37.0K $34.0K $34.0K $26.0K · ·
Accum. Depreciation 4-point trend, +54.5% $34.0K $30.0K $26.0K $22.0K · ·
Other Non-current Assets 3-point trend, -100.0% · · · $0 $206.0K $279.0K
Total Assets 6-point trend, +807.4% $9M $6M $3M $383.0K $8M $955.0K
Accounts Payable 6-point trend, +49.8% $2M $897.0K $1M $1M $918.0K $1M
Accrued Liabilities 6-point trend, -11.5% $750.0K $691.0K $1M $36.0K $1M $847.0K
Short-term Debt 4-point trend, -100.0% · · $0 $602.0K $0 $47.0K
Current Liabilities 6-point trend, +18.8% $3M $2M $3M $2M $2M $2M
Capital Leases 4-point trend, +7.1% $15.0K $71.0K $0 $14.0K · ·
Other Non-current Liabilities 3-point trend, -100.0% · · · $0 $72.0K $170.0K
Total Liabilities 6-point trend, +10.3% $3M $2M $3M $2M $3M $2M
Total Debt Flat — no change across 2 periods · · $0 · $0 ·
Paid-in Capital · · · · · $11M
Retained Earnings 6-point trend, -310.3% $-52M $-40M $-32M $-18M $-22M $-13M
AOCI 3-point trend, +0.00 · · · $0 $-2.0K $0
Stockholders' Equity 6-point trend, +513.2% $6M $4M $259.0K $-2M $-5M $-1M
Liabilities + Equity 6-point trend, +807.4% $9M $6M $3M $383.0K $8M $955.0K
Shares Outstanding 6-point trend, -89.0% 497,693 18,768 104 646 121,631 4,506,216
Cash Flow 9
Annual Cash Flow data for GRI
Metric Trend 202520242023202220212020
Stock-based Comp 6-point trend, +414.9% $793.0K $148.0K $388.0K $25.0K $626.0K $154.0K
Operating Cash Flow 6-point trend, -174.9% $-10M $-9M $-9M $-1M $-8M $-4M
CapEx 6-point trend, +50.0% $3.0K $0 $8.0K $3.0K $0 $2.0K
Investing Cash Flow 6-point trend, -50.0% $-3.0K $0 $-8.0K $-3.0K $-4M $-2.0K
Stock Issued 2-point trend, +12250000.00 · · $12M $0 · ·
Net Stock Activity · · $12M · · ·
Financing Cash Flow 6-point trend, +334850.0% $13M $12M $11M $1M $16M $-4.0K
Net Change in Cash 6-point trend, +186.2% $3M $3M $2M $-81.0K $4M $-4M
Free Cash Flow 4-point trend, -22.6% $-10M $-9M $-9M · $-8M ·
Profitability 2
Annual Profitability data for GRI
Metric Trend 202520242023202220212020
ROA 5-point trend, +17.1% -166.0% -188.8% -780.9% -112.5% -200.3% ·
ROE 5-point trend, -100.4% -256.3% -213.4% -1048.8% 417.6% -127.9% ·
Liquidity & Solvency 3
Annual Liquidity & Solvency data for GRI
Metric Trend 202520242023202220212020
Current Ratio 5-point trend, -2.2% 3.3 3.4 1.1 2.3 3.3 ·
Quick Ratio 5-point trend, +105.6% 3.1 3.1 0.7 2.1 1.5 ·
Debt / Equity Flat — no change across 2 periods · · 0.0 · 0.0 ·
Efficiency 1
Annual Efficiency data for GRI
Metric Trend 202520242023202220212020
Asset Turnover · · · · 0.0 ·
Per Share 5
Annual Per Share data for GRI
Metric Trend 202520242023202220212020
Book Value / Share 5-point trend, +1313.5% $12.07 $7.67 $0.40 $0.17 $0.85 ·
Revenue / Share · · · · $0.00 ·
Cash Flow / Share 5-point trend, -8066.1% $-103.77 $-46.98 $-19.48 $-0.70 $-1.27 ·
Cash / Share 5-point trend, +2942.7% $16.53 $9.57 $2.80 $0.28 $0.54 ·
EPS (TTM) 6-point trend, -11283.2% $-121.80 $-1545.55 $-5018.09 $-24.95 $-1.42 $-1.07
Valuation (TTM) 12
Annual Valuation (TTM) data for GRI
Metric Trend 202520242023202220212020
Revenue TTM 6-point trend, -100.0% $0 $0 $0 $0 $0 $100.0K
Net Income TTM 6-point trend, -147.9% $-12M $-8M $-13M $-3M $-9M $-5M
Market Cap 5-point trend, -100.0% $122.9K $7M $385M $181.46B $1.89T ·
Enterprise Value 2-point trend, -100.0% · · $383M · $1.89T ·
P/E 5-point trend, +100.0% -0.0 -0.0 -0.1 -539.4 -195444.9 ·
P/B 5-point trend, -100.0% 0.0 1.8 1484.9 77479.7 324987.7 ·
P / Tangible Book 3-point trend, -100.0% 0.0 1.8 1484.9 · · ·
P / Cash Flow 5-point trend, +100.0% -0.0 -0.9 -42.8 -25432.0 -227475.8 ·
P / FCF 4-point trend, +100.0% -0.0 -0.9 -42.7 · -227475.8 ·
EV / EBITDA 2-point trend, +100.0% · · -33.6 · -204209.4 ·
EV / FCF 2-point trend, +100.0% · · -42.5 · -227475.3 ·
Earnings Yield 5-point trend, -493.12 -49311.7% -10980.0% -842.5% -0.19% 0.00% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $0
Net Income $-12M$-8M$-13M$-3M$-9M
Diluted EPS $-121.80$-1545.55$-5018.09$-24.95$-1.42
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.00.0
Current Ratio 3.33.41.12.33.3
Quick Ratio 3.13.10.72.11.5
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-10M$-9M$-9M$-8M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 12 filers · $112K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
6 (+1 vs prior Q) 1 (-1 vs prior Q) 1 (+1 vs prior Q) 2 (+1 vs prior Q) +65K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD CAPITAL MANAGEMENT LLC $37,821 21,368 33.72% Shares
CITADEL ADVISORS LLC $23,676 13,376 21.11% Shares
GEODE CAPITAL MANAGEMENT, LLC $17,779 10,045 15.85% Shares
MORGAN STANLEY $15,464 8,737 13.79% Shares
UBS Group AG $8,708 4,920 7.76% Shares
Tower Research Capital LLC (TRC) $4,308 2,434 3.84% Shares
VANGUARD GROUP INC $4,199 17,000 3.74% Shares
BARCLAYS PLC $147 83 0.13% Shares
HRT FINANCIAL LP $50 28,784 0.04% Shares
BlackRock, Inc. $12 7 0.01% Shares
Caitong International Asset Management Co., Ltd $4 2 0.00% Shares
DANSKE BANK A/S $4 2 0.00% Shares

Company insiders 8 insiders · 2 officers · 5 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
David Charles Baker Chief Executive Officer May 14, 2021 A 8,843 0 0 $0
Penny Toren SVP, Regul Affairs & Prog Mgmt May 14, 2021 A 0 0 $0
Joseph E Payne Director May 26, 2021 P 17,500 0 0 $0
Richard Ammer Director May 14, 2021 A 47,063 0 0 $0
Ofir Levi Director May 14, 2021 A 0 0 $0
Marella Thorell Director Feb. 12, 2021 A 0 0 $0
SALMON Pharma GmbH 10% owner Feb. 12, 2021 J 47,063 0 0 $0
Leanne M. Kelly Sept. 18, 2025 A 6,250 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 5 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Albert Agro April 25, 2023 Initial filing SEC
W. Marc Hertz April 25, 2023 Initial filing SEC
Vipin Kumar Chaturvedi April 25, 2023 Initial filing SEC
Undisclosed reporting person, Undisclosed reporting person March 16, 2021 Initial filing SEC
Undisclosed reporting person, Undisclosed reporting person Feb. 16, 2021 Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 21 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS July 15, 2026 Daily
VXUS · VANGUARD STAR FUNDS July 15, 2026 Daily
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… July 15, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… July 15, 2026 Daily
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… July 15, 2026 Daily
VNQI · VANGUARD INTERNATIONAL EQUITY INDEX… July 15, 2026 Daily
VEA · VANGUARD TAX-MANAGED FUNDS July 15, 2026 Daily
PDN · Invesco Exchange-Traded Fund Trust … July 13, 2026 Daily
VSGX · VANGUARD WORLD FUND July 30, 2026 Daily
IEUS · iShares Trust July 20, 2026 Daily
IFGL · iShares Trust July 20, 2026 Daily
SCZ · iShares Trust Aug. 18, 2026 Daily
EWUS · iShares Trust July 20, 2026 Daily
IEFA · iShares Trust July 24, 2026 Daily
IXUS · iShares Trust Aug. 17, 2026 Daily
IEUR · iShares Trust Aug. 17, 2026 Daily
REET · iShares Trust July 30, 2026 Daily
ISCF · iShares Trust July 20, 2026 Daily
IDEV · iShares Trust July 22, 2026 Daily
ERET · iShares Trust July 20, 2026 Daily
WSML · iShares Trust July 20, 2026 Daily